Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.02 EUR | -0.58% | -1.92% | -10.90% |
Mar. 18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Mar. 18 | Fresenius Settles With Johnson & Johnson to Market Stelara Alternative | DJ |
Official Publications
- Stock
- Equities
- Stock Fresenius SE & Co. KGaA - Xetra
- News Fresenius SE & Co. KGaA
- Official Publications